Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct 26;13(11):3793.
doi: 10.3390/nu13113793.

The Role of 20-HETE, COX, Thromboxane Receptors, and Blood Plasma Antioxidant Status in Vascular Relaxation of Copper-Nanoparticle-Fed WKY Rats

Affiliations

The Role of 20-HETE, COX, Thromboxane Receptors, and Blood Plasma Antioxidant Status in Vascular Relaxation of Copper-Nanoparticle-Fed WKY Rats

Michał Majewski et al. Nutrients. .

Abstract

Recently, the addition of copper nanoparticles (NPs) in a daily diet (6.5 mg/kg) was studied in different animal models as a possible alternative to ionic forms. Male Wistar-Kyoto rats (24-week-old, n = 11) were fed with copper, either in the form of carbonate salt (Cu6.5) or metal-based copper NPs (NP6.5), for 8 weeks. The third group was fed with a half dose of each (NP3.25 + Cu3.25). The thoracic aorta and blood plasma was studied. Supplementation with NP6.5 decreased the Cu (×0.7), Cu/Zn-ratio (×0.6) and catalase (CAT, ×0.7), and increased Zn (×1.2) and superoxide dismutase (SOD, ×1.4). Meanwhile, NP3.25 + Cu3.25 decreased the Cu/Zn-ratio (×0.7), and CAT (×0.7), and increased the daily feed intake (×1.06). Preincubation with either the selective cyclooxygenase (COX)-2 inhibitor, or the non-selective COX-1/2 inhibitor attenuated vasodilation of rat thoracic aorta in the NP6.5 group exclusively. However, an increased vasodilator response was observed in the NP6.5 and NP3.25 + Cu3.25 group of rats after preincubation with an inhibitor of 20-hydroxyeicosatetraenoic acid (20-HETE) formation, and the thromboxane receptor (TP) antagonist. Significant differences were observed between the NP6.5 and NP3.25 + Cu3.25 groups of rats in: dietary intake, acetylcholine-induced vasodilation, and response to COX-inhibitors. Copper NPs in a standard daily dose had more significant effects on the mechanism(s) responsible for the utilization of reactive oxygen species in the blood plasma with the participation of prostanoids derived from COX-2 in the vascular relaxation. Dietary copper NPs in both doses modified vasodilation through the vasoconstrictor 20-HETE and the TP receptors.

Keywords: 20-HETE; HET0016; NS-398; SQ-29,548; aging; furegrelate; indomethacin; thromboxane-A2.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Figures

Figure 1
Figure 1
The influence of experimental diets on rat body weight (AC), and daily feed intake (D). Values are expressed as means ± SD of n = 11 rats (AC), and of m = 56 days of supplementation (D). NP3.25 + Cu3.25 increased by 1.06-fold the daily feed intake.
Figure 2
Figure 2
The influence of experimental diets on Cu, Zn content (AC), and antioxidant mechanism (DH) in blood plasma. Values are expressed as means ± SD of n = 11 rats. Supplementation with NP6.5 decreased the Cu (×0.7), Cu/Zn-ratio (×0.6), catalase (CAT, ×0.7), and increased Zn (×1.2), and superoxide dismutase (SOD, ×1.4). NP3.25 + Cu3.25 decreased the Cu/Zn-ratio (×0.7), and CAT (×0.7).
Figure 3
Figure 3
The relaxant response to acetylcholine in the isolated thoracic rings from rats supplemented with Cu6.5, NP3.25 + Cu3.25, and NP6.5. Results are means ± SEM, * compared to Cu6.5, # compared to NP3.25 + Cu3.25, p < 0.05 of n = 11 rats; ANOVA/Tukey’s. The red curve is the nonlinear regression model (log agonist vs. response). A significant change in the relaxant response was observed between the NP3.25 + Cu3.25 and NP6.5 groups of rats.
Figure 4
Figure 4
The influence of 1400 W on the relaxant response to acetylcholine. Aortic rings from rats supplemented with Cu6.5 (A), NP3.25 + Cu3.25 (B), and NP6.5 (C) were pre-incubated with the inducible nitric oxide synthase inhibitor (1400 W, 30 min, 1 μM). Results are means ± SEM, p > 0.05 of n = 5 rats; two-way ANOVA/Sidak’s. Preincubation with the selective iNOS inhibitor did not modify the vasodilation.
Figure 5
Figure 5
The influence of NS-398 and indomethacin (Indo) on the relaxant response to acetylcholine. Aortic rings from rats supplemented with Cu6.5 (A), NP3.25 + Cu3.25 (B), and NP6.5 (C) were pre-incubated with the selective cyclooxygenase-2 (COX-2) inhibitor (NS-398, 30 min, 10 μM) and the non-selective COX-1/2 inhibitor (Indo, 30 min, 10 μM). Results are means ± SEM, * p < 0.05 of n = 5 rats; ANOVA/Tukey’s. Preincubation with NS-398 and indomethacin attenuated vasodilation of rat thoracic aorta in the NP6.5 group exclusively.
Figure 6
Figure 6
The influence of HET0016 on the relaxant response to acetylcholine. Aortic rings from rats supplemented with Cu6.5 (A), NP3.25 + Cu3.25 (B), and NP6.5 (C) were pre-incubated with an inhibitor of 20-HETE formation (HET0016, 30 min, 0.1 μM). Results are the means ± SEM, * p < 0.05 two-way ANOVA/Sidak’s. Number of animals is indicated in parenthesis. Preincubation with HET0016 potentiated vasodilation in NP3.25 + Cu3.25, and NP6.5 fed rats. This was not observed in the control group (Cu6.5).
Figure 7
Figure 7
The influence of furegrelate and SQ-29,548 on the relaxant response to acetylcholine. Aortic rings from rats supplemented with Cu6.5 (A), NP3.25 + Cu3.25 (B), and NP6.5 (C) were pre-incubated with the thromboxane-A2 synthetase inhibitor (FURE, 30 min, 1 μM) and the thromboxane-A2 receptor antagonist (SQ-29,548, 30 min, 1 μM). Results are means ± SEM, * p < 0.05; ANOVA/Tukey’s. Number of animals is indicated in parenthesis. SQ-29,548 potentiated vasodilation in the NP3.25 + Cu3.25 and in the NP6.5 group of rats.

References

    1. Majewski M., Lis B., Olas B., Ognik K., Juśkiewicz J. Dietary supplementation with copper nanoparticles influences the markers of oxidative stress and modulates vasodilation of thoracic arteries in young Wistar rats. PLoS ONE. 2020;15:e0229282. doi: 10.1371/journal.pone.0229282. - DOI - PMC - PubMed
    1. Majewski M., Ognik K., Juśkiewicz J. Copper nanoparticles modify the blood plasma antioxidant status and modulate the vascular mechanisms with nitric oxide and prostanoids involved in Wistar rats. Pharmacol. Rep. 2019;71:509–516. doi: 10.1016/j.pharep.2019.02.007. - DOI - PubMed
    1. Majewski M., Ognik K., Juśkiewicz J. The interaction between resveratrol and two forms of copper as carbonate and nanoparticles on antioxidant mechanisms and vascular function in Wistar rats. Pharmacol. Rep. 2019;71:862–869. doi: 10.1016/j.pharep.2019.03.011. - DOI - PubMed
    1. Tang H., Xu M., Luo J., Zhao L., Ye G., Shi F., Lv C., Chen H., Wang Y., Li Y. Liver toxicity assessments in rats following sub-chronic oral exposure to copper nanoparticles. Environ. Sci. Eur. 2019;31:30. doi: 10.1186/s12302-019-0214-0. - DOI
    1. Galhardi C.M., Diniz Y.S., Faine L.A., Rodrigues H.G., Burneiko R.C.M., Ribas B.O., Novelli E.L. Toxicity of copper intake: Lipid profile, oxidative stress and susceptibility to renal dysfunction. Food Chem. Toxicol. 2004;42:2053–2060. doi: 10.1016/j.fct.2004.07.020. - DOI - PubMed

MeSH terms